Meeting the Patients Where They Are: A Case Study in Treatment Landscape Mapping and its Impact on Site Selection as a Result of Partnering with a Patient Advocacy Organization
March 3, 11:35am CEST
Patient Partnering in Clinical Development
The role of Patient Advocacy Organizations (PAOs) has been evolving over the past few decades and the impact that PAOs can have in the planning, design and execution of clinical research trials has been expanding. It is not unusual for PAOs or even individual patients and/or their care network members to be involved in the identification or refinement of disease-specific endpoints, to offer insights on protocol design or to offer advice on enrollment or retention obstacles and how to overcome them. Indeed, the industry has come to realize the benefits of engaging with patients and their care partners at almost every step of the clinical development process.
In this presentation we will explore how a CRO’s engagement with a specific PAO impacted the country and site mix in a rare disease trial, resulting in a complete change in site selection strategy. This engagement resulted in the first ever trial in this indication being placed in this specific country, all as a result of the efforts of the PAO and the CRO to dig deeper and work together to understand the treatment landscape in that country.
Juliet Moritz, VP, Patient & Stakeholder Engagement